Anna Pimenova

Anna Pimenova, PhD, is a distinguished Senior Project Manager at miDiagnostics since June 2022, with previous experience as a Scientific Project Manager at Immunai, where operations in cross-functional laboratory R&D and healthcare data management were optimized for multi-omic single-cell sequencing. Anna's academic background includes a role as an Instructor and Postdoctoral Fellow at the Icahn School of Medicine at Mount Sinai, where a novel technology for Alzheimer's disease was successfully licensed for commercialization. Additional experience encompasses business development at Mount Sinai Innovation Partners, evaluating technologies for patentability, and participation as a Research Scholar at TEDMED. Anna has also made contributions in industry settings, such as characterizing compounds for Alzheimer's research with Janssen Pharmaceuticals and studying the impact of heat shock proteins on cancer and immune response at the Institute of Cytology. Anna holds a Ph.D. in Biomedical Sciences from KU Leuven and an Engineer's degree in Biotechnology from Saint Petersburg State Institute of Technology, graduating summa cum laude.